Wealthspire Advisors, LLC Novo Nordisk A S Transaction History

Wealthspire Advisors, LLC

  • $9.71 Billion
  • Q3 2024

A detailed history of Wealthspire Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 15,888 shares of NVO stock, worth $1.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,888
Previous 9,045 75.66%
Holding current value
$1.39 Million
Previous $1.29 Million 46.48%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$119.07 - $145.42 $814,796 - $995,109
6,843 Added 75.66%
15,888 $1.89 Million
Q2 2024

Aug 08, 2024
SELL
$122.71 - $146.91 $11,902 - $14,250
-97 Reduced 1.06%
9,045 $1.29 Million
Q1 2024

May 06, 2024
BUY
$102.11 - $135.92 $128,760 - $171,395
1,261 Added 16.0%
9,142 $1.17 Million
Q4 2023

Feb 06, 2024
SELL
$87.78 - $105.45 $53,633 - $64,429
-611 Reduced 7.2%
7,881 $815,000
Q3 2023

Nov 06, 2023
BUY
$90.94 - $199.54 $467,704 - $1.03 Million
5,143 Added 153.57%
8,492 $772,000
Q2 2023

Jul 31, 2023
BUY
$155.98 - $172.65 $32,599 - $36,083
209 Added 6.66%
3,349 $541,000
Q1 2023

May 09, 2023
SELL
$132.34 - $159.14 $263,091 - $316,370
-1,988 Reduced 38.77%
3,140 $499,000
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $167,669 - $221,264
1,635 Added 46.81%
5,128 $693,000
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $77,557 - $95,181
814 Added 30.38%
3,493 $348,000
Q2 2022

Aug 09, 2022
SELL
$103.24 - $121.81 $5,162 - $6,090
-50 Reduced 1.83%
2,679 $299,000
Q1 2022

May 09, 2022
SELL
$93.1 - $112.54 $180,707 - $218,440
-1,941 Reduced 41.56%
2,729 $303,000
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $28,476 - $34,772
-297 Reduced 5.98%
4,670 $523,000
Q3 2021

Nov 15, 2021
BUY
$84.42 - $106.62 $113,544 - $143,403
1,345 Added 37.13%
4,967 $477,000
Q2 2021

Aug 13, 2021
SELL
$67.66 - $84.76 $116,104 - $145,448
-1,716 Reduced 32.15%
3,622 $303,000
Q1 2021

May 17, 2021
BUY
$67.06 - $75.82 $25,818 - $29,190
385 Added 7.77%
5,338 $360,000
Q4 2020

Feb 16, 2021
BUY
$63.89 - $73.8 $316,447 - $365,531
4,953 New
4,953 $346,000
Q2 2020

Aug 14, 2020
SELL
$58.54 - $67.94 $1.05 Million - $1.21 Million
-17,856 Closed
0 $0
Q1 2020

May 12, 2020
BUY
$49.46 - $64.78 $883,157 - $1.16 Million
17,856 New
17,856 $1.08 Million
Q1 2019

May 08, 2019
SELL
$46.36 - $52.63 $46,406 - $52,682
-1,001 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$41.54 - $47.25 $41,581 - $47,297
1,001 New
1,001 $46,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wealthspire Advisors, LLC Portfolio

Follow Wealthspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email